Iovance Biotherapeutics, Inc. IOVA Enterprise value

Enterprise value at other companies

Bristol-Myers SquibbBMY

$152.27B+14.9%

Gilead SciencesGILD

$179.93B+17.5%

ImmunityBio, Inc.IBRX

$8.16B+187%

Cullinan Therapeutics, Inc.CGEM

$1.04B+166%

Artiva Biotherapeutics, Inc.ARTV

$179.24M+662%

IncyteINCY

$18.7B+63.4%

FAQ

What is Iovance Biotherapeutics, Inc.'s enterprise value?

Iovance Biotherapeutics, Inc. (IOVA) reported enterprise value of $1.79B in Q2 2026.

How has Iovance Biotherapeutics, Inc.'s enterprise value changed year-over-year?

Iovance Biotherapeutics, Inc.'s enterprise value increased by 227.4% year-over-year, from $547.49M to $1.79B.

What is the long-term trend for Iovance Biotherapeutics, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s enterprise value has grown at a -32.3% compound annual growth rate (CAGR), from $6.82B to $969.09M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.